The size of the Middle East & Africa Varicose Vein Treatment Market was worth USD 20.81 million in 2022 and estimated to be growing at a CAGR of 5.25%, to reach USD 26.87 million by 2027.
The rising incidence of varicose veins primarily drives the varicose vein treatment market. This condition of enlarged, gnarled veins, appearing mostly in the feet and legs, is caused by several factors, including pregnancy, hormonal changes, genetic disorders, obesity, sleep disorders, high blood pressure levels, and lifestyle-associated factors such as prolonged standing and increased stress levels.
The market is majorly driven by bettering patient compliance owing to the advent of durable and safe techniques to address the huge burden of varicose vein incidences and the increased access to varicose vein medical devices. The healthcare industry has also experienced a new trend of removing or destroying the surface veins with enhanced patient experience. However, the dearth of trained vascular surgeons and the high cost of varicose vein treatment procedures can hinder this market's growth.
This research report segmented and sub-segmented the Middle East and Africa Varicose Vein Treatment Market into the following categories.
By Treatment Types:
By Device:
By End-User:
By Country:
Some of the companies leading the Middle East & Africa Varicose Vein Treatment Market profiled in the report are Medtronic plc (Ireland), AngioDynamics, Inc. (U.S.), biolitec AG (Austria), Syneron Medical Ltd. (Israel), Lumenis Ltd. (Israel), Dornier MedTech GmbH (Germany), Energist Group (U.K.), Eufoton s.r.l. (Italy), Vascular Solutions, Inc. (U.S.), Quanta System S.p.A. (Italy), Sciton, Inc. (U.S.), Fotona d.o.o. (Slovenia), BTG plc (U.K.), Merz Aesthetics (U.S.).
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Treatment
5.1.1 Introduction
5.1.2 Endovenous ablation
5.1.3 Surgical litigation/ Stripping
5.1.4 Sclerotherapy
5.1.5 Y-o-Y Growth Analysis, By Treatment
5.1.6 Market Attractiveness Analysis, By Treatment
5.1.7 Market Share Analysis, By Treatment
5.2 Product
5.2.1 Introduction
5.2.2 Ablation devices
5.2.2.1 Radiofrequency ablation devices
5.2.2.2. Laser ablation devices
5.2.3 Venous closure products
5.2.4 Surgical products
5.2.5 Y-o-Y Growth Analysis, By Product
5.2.6 Market Attractiveness Analysis, By Product
5.2.7 Market Share Analysis, By Product
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Treatment
6.1.3.3 By Product
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Treatment
6.1.4.3 By Product
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Treatment
6.1.5.3 By Product
6.2 Middle-East
6.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Medtronic plc
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 AngioDynamics, Inc.
8.3 Syneron Medical Ltd.
8.4 Lumenis Ltd.
8.5 Dornier MedTech GmbH
8.6 Energist Group
8.7 Vascular Solutions, Inc.
8.8 Merz Aesthetics
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
